Nanexa is a pioneering pharmaceutical company dedicated to the development of innovative drug delivery systems. At the forefront of its technological advancements is the PharmaShell® technology, designed for long acting injectables. This cutting-edge technology harnesses the power of nanotechnology to create a shell around the active pharmaceutical ingredient, enabling controlled and sustained release over extended periods. PharmaShell® holds the potential to transform treatment paradigms across various therapeutic areas by improving patient compliance, reducing dosing frequency, and enhancing efficacy. Nanexa’s commitment to innovation and excellence in drug delivery is underscored by its robust research and development efforts and strategic collaborations with industry leaders. As Nanexa presents PharmaShell® at this conference, it aims to showcase the technology’s capabilities and its impact on the future of long acting injectables, fostering new partnerships and advancing the field of pharmaceutical sciences.